HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shimpei Sato Selected Research

Shimpei Sato Research Topics

Disease

6Hypertension (High Blood Pressure)
12/2017 - 11/2015
3Neoplasms (Cancer)
03/2022 - 10/2020
3Polypoidal Choroidal Vasculopathy
01/2020 - 01/2017
3Carotid Artery Diseases
07/2018 - 04/2014
3Atherosclerosis
01/2017 - 04/2014
2Clinical Deterioration
06/2020 - 09/2016
2Polyps
01/2020 - 01/2017
2Macular Degeneration (Age-Related Maculopathy)
11/2018 - 09/2016
2Open-Angle Glaucoma (Glaucoma, Open Angle)
10/2017 - 02/2017
2Glaucoma
10/2017 - 02/2017
2Edema (Dropsy)
09/2016 - 05/2010
1Endometrial Neoplasms (Endometrial Cancer)
03/2022
1Inflammation (Inflammations)
01/2019
1Eye Diseases (Eye Disease)
01/2019
1Fibrosis (Cirrhosis)
11/2018
1Sarcopenia
07/2018
1Vascular Remodeling
01/2018
1Dehydration (Water Stress)
01/2018
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2017
1Chronic Renal Insufficiency
11/2015
1Cardiovascular Diseases (Cardiovascular Disease)
04/2015
1Hyperlipidemias (Hyperlipidemia)
04/2015
1Retinal Vein Occlusion
01/2015
1Macular Edema
01/2015
1Congenital Toxoplasmosis
11/2014
1Vomiting
11/2014
1Teratoma (Teratoid Tumor)
05/2014
1Anemia
04/2014
1Hyperuricemia
04/2014
1Hyperlipoproteinemia Type III (Broad Beta Disease)
11/2013
1Hypertriglyceridemia
11/2013
1Pancreatitis
11/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2012
1Choroidal Effusions
08/2012
1Retinal Detachment (Retinal Detachments)
09/2010
1Choroidal Neovascularization
05/2010
1Capsule Opacification
01/2010
1Cataract (Cataracts)
01/2010

Drug/Important Bio-Agent (IBA)

5ORALIT (ORS)IBA
07/2018 - 04/2014
5Hemoglobins (Hemoglobin)IBA
01/2018 - 04/2014
4afliberceptIBA
01/2020 - 09/2016
4Indicators and Reagents (Reagents)IBA
07/2018 - 07/2016
3Triglycerides (Triacylglycerol)IBA
11/2017 - 11/2013
2Ranibizumab (Lucentis)FDA Link
01/2020 - 09/2016
2K-115IBA
10/2017 - 02/2017
2rho-Associated KinasesIBA
10/2017 - 02/2017
1Chromogranin AIBA
03/2022
1Keratin-20 (Cytokeratin 20)IBA
03/2022
1Immune Checkpoint InhibitorsIBA
01/2021
1Melanins (Melanin)IBA
10/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2020
1Carotenoids (Carotene)IBA
01/2019
1PolyphenolsIBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018
1N-acetyltryptophanamide (NATA)IBA
10/2018
1HDL CholesterolIBA
06/2017
1Glucose (Dextrose)FDA LinkGeneric
04/2015
1Sulfadiazine (Sulphadiazine)FDA Link
11/2014
1acetylspiramycinIBA
11/2014
1Pyrimethamine (Daraprim)FDA Link
11/2014
1polyacrylamideIBA
11/2013
1Lipoproteins (Lipoprotein)IBA
11/2013
1Apolipoprotein E3IBA
11/2013
1Eicosapentaenoic AcidIBA
11/2013
1Bevacizumab (Avastin)FDA Link
05/2010

Therapy/Procedure

4Therapeutics
01/2021 - 01/2017
3Retreatment
06/2020 - 05/2010
3Injections
01/2020 - 01/2017
3Vitrectomy
01/2015 - 01/2010
2Intravitreal Injections
10/2018 - 05/2010
1Photochemotherapy (Photodynamic Therapy)
01/2020
1Drug Therapy (Chemotherapy)
11/2014
1Lymph Node Excision (Lymph Node Dissection)
05/2014
1Adjuvant Chemotherapy
05/2014
1Hysterectomy
05/2014
1Salpingo-oophorectomy
05/2014
1Cord Blood Stem Cell Transplantation
08/2012
1Posterior Capsulotomy
01/2010